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Abstract
Background: A substantial proportion of men who have sex with men (MSM) in the United States remain unvaccinated
against hepatitis B. We sought to understand which factors are associated with vaccination among HIV-negative MSM.
Methodology/Principal Findings: Data were from a 2010 web-based survey of adult MSM. We calculated the prevalence of
self-reported hepatitis B vaccination among 1,052 HIV-negative or HIV-untested men who knew their hepatitis B vaccination
status, and used multivariate logistic regression to determine associated factors. 679 (64.5%) MSM reported being
vaccinated. Younger men were more likely to report being vaccinated than older men, and there was a significant
interaction between age and history of hepatitis B testing. Men with at least some college education were at least 2.1 times
as likely to be vaccinated as men with a high school education or less (95% CI=1.4–3.1). Provider recommendation for
vaccination (aOR=4.2, 95% CI=2.4–7.4) was also significantly associated with receipt of vaccination.
Conclusions/Significance: Providers should assess sexual histories of male patients and offer those patients with male sex
partners testing for hepatitis infection and vaccinate susceptible patients. There may be particular opportunities for
screening and vaccination among older and more socioeconomically disadvantaged MSM.
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Introduction
As part of their sexually transmitted disease treatment
guidelines, the US Centers for Disease Control and Prevention
recommends that all MSM with multiple sex partners should
be vaccinated against hepatitis B [1,2]. A hepatitis B vaccine has
been available in the United States since licensure in 1981, and
vaccination has been recommended for MSM, as well as other
high-risk adults, healthcare workers, and infants born to hepatitis
B-positive mothers since 1982 [3]. Vaccine recommendations were
expanded in 1991 to cover all infants, as well as adolescents who
engage in high-risk sexual and non-sexual behaviors [4], and, by
1997, all children under the age of 18 [5]. Hepatitis B vaccine is
not administered to individuals who have serological evidence of
previous infection.
Although heterosexual contact remains the primary mode of
transmission of hepatitis B among adults, the disease burden
associated with male-male sexual contact is substantial: as of 2005,
one in four incident cases of hepatitis B was reported among MSM
[1]. The prevalence of hepatitis B infection among MSM has been
significantly reduced in part due to the development of a hepatitis
B vaccine: in the 1970s, 3 in 5 MSM had serologic evidence of
prior infection [6,7]; after 1981, when the vaccine was licensed,
less than one in three MSM has ever been infected with hepatitis B
[8–14].
Despite substantial reductions in the prevalence of infection,
nationally representative surveys have indicated that fewer than
one in five young MSM has serologic evidence of vaccination
against hepatitis B [11,12]. By contrast, self-reported hepatitis B
vaccination rates are often much higher: Finlayson et al reported
in 2011 that 48% of MSM interviewed for the National HIV
Behavioral Surveillance System reported ever having been
vaccinated against hepatitis B [15]. Self-reported vaccination rates
among MSM in select cities across the United States have been
more variable, ranging from 3% to 70% [13,14,16–18].
A number of recent studies have presented analyses that
describe demographic and behavioral factors associated with
receipt of hepatitis B vaccination among MSM. However, many of
these studies are from limited geographic areas, from restricted age
groups, or are confined to respondents from urban areas. Thus,
the results of past studies may not be reflective of patterns of self-
reported vaccination among MSM across the United States.
Multisite studies of self-reported hepatitis B vaccination prevalence
and factors associated with vaccination have been conducted
among younger MSM in larger US cities [11,12]. In addition, a
number of previous studies have not evaluated the statistical
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[8,13,17].
To address these gaps in previous studies, we used data from a
national online survey of MSM to describe the prevalence of
hepatitis B vaccination in HIV-negative MSM. Using logistic
regression models, we evaluated factors associated with receipt of
self-reported vaccination among these men. In addition, we
described self-reported reasons for lack of vaccination among
MSM who were not vaccinated against hepatitis B.
Methods
Ethics Statement
The present study received institutional review board exemp-
tion from the Emory University Institutional Review Board
(IRB00044470). No identifying information was collected from
respondents. Prior to being shown any study-related questions, all
participants were informed they could skip any question they did
not feel comfortable answering, and most questions also allowed
participants to indicate that they did not know the answer or
preferred not to answer.
We recruited men to a web-based sexual health survey through
banner ad recruitment. We displayed banner advertisements for a
men’s health survey to men living in the United States who
reported being interested in men on the social networking Internet
site Facebook (http://www.facebook.com), and to members of the
site Black Gay Chat (http://www.bgclive.com) from October 28 to
December 12, 2010. Men who clicked through the banner
advertisement were forwarded to a web page with a series of
screening questions. Individuals were eligible for participation in
the survey if they were male and 18 years of age or older. All
female respondents, as well as those male respondents who were
under 18 years of age or who did not specify their age, were
screened out of our study and were not presented with any
additional study-related questions. Consenting study participants
were asked a series of questions related to demographic
characteristics (race and ethnicity; educational, employment and
insurance status; state of residence); experiences as a gay or
bisexual man; lifetime history of sexual partners; characteristics of
the participant’s most recent male sex partner (MRMSP)
[including demographic characteristics and information on the
partner’s HIV status]; sexual (oral and anal intercourse; condom
use) and non-sexual (drug use) risk behaviors engaged in at last sex
with the MRMSP; HIV knowledge, testing behaviors and status;
having had a care visit with a healthcare provider in the last 12
months; and hepatitis B diagnosis, testing and vaccination status.
Our primary analytic objective was to determine the prevalence
of and factors associated with self-reported receipt of hepatitis B
vaccination among MSM. Therefore, participants were excluded
from our analysis if they reported having sex with only women,
reported never having sex, or did not specify a history of sexual
partners. In particular, we were interested in evaluating the extent
of hepatitis B vaccination among HIV-negative MSM. Therefore,
MSM who were HIV-positive or who did not specify or know
whether they had ever been tested for HIV, as well as men who
had been tested for HIV but chose not to report their HIV status,
were excluded from our analysis.
Participants who remained in our analysis sample were included
in univariate analysis of all independent predictors. To assess
hepatitis B vaccination coverage, participants were asked ‘‘Have
you ever had a vaccine for hepatitis?’’ and ‘‘What type(s) of
hepatitis vaccine have you had?’’ Individuals could choose from
‘‘hepatitis A vaccine,’’ ‘‘hepatitis B vaccine,’’ ‘‘hepatitis A and B
vaccine’’ or ‘‘I’m not sure which hepatitis vaccine I got.’’
Respondents who reported receiving ‘‘hepatitis B vaccine’’ or
‘‘hepatitis A and B vaccine’’ were classified as having received a
vaccine for hepatitis B. Respondents who reported, ‘‘I’m not sure
which hepatitis vaccine I got,’’ were excluded from the analysis. In
this study, we evaluated the association of age, race/ethnicity,
educational and insurance status, state of residence, lifetime
history of sexual partners, anal intercourse, condom and drug use
engaged in at last sex with the MRMSP, HIV testing behavior,
having had a care visit with a healthcare provider in the last 12
months, and hepatitis B diagnosis and testing status with hepatitis
B vaccination among MSM using chi-square tests of general
association and bivariate odds ratios.
Men who reported having received a positive test result for
hepatitis antibodies were excluded from bivariate analyses because
hepatitis B vaccination is not recommended for individuals who
have serological evidence of prior hepatitis B infection. Variables
with bivariate chi-square p-values of less than 0.20 were entered
into the initial multivariable model. The final main effects were
determined using a backward selection algorithm wherein all
variables not significant at a 5% alpha level were removed from
the model. Once a main effects model containing all significant
covariates was developed, the presence of two-way interactions
was evaluated using a forward selection algorithm. We employed a
Bonferroni-type correction in order to set the overall type I error
rate for interactions at 5%. Multicollinearity of covariates and
their interactions was assessed using the SAS macro COLLIN
[19]. Collinearity was considered to be present if the condition
index was .30.
We also compiled self-reported reasons why unvaccinated MSM
were not vaccinated against hepatitis B. Men who reported never
having been vaccinated against hepatitis B were asked to endorse
all the reasons to explain why they had never been vaccinated
from a specified list of reasons, as well as one ‘‘main’’ reason for
lack of vaccination (for those participants who selected multiple
reasons). Responses to this question were adapted from a study of
viral hepatitis infection and vaccination among MSM that was
conducted by Diamond et al on behalf of the US Young Men’s
Survey team [10]. If only one reason was reported, that reason was
assumed to be the ‘‘main’’ reason for not being vaccinated against
hepatitis B.
All analyses were performed using SAS 9.2 (SAS Institute, Cary,
NC, USA).
Results
2,085 men aged 18 years of age or older were eligible to
participate in our study. Of these, 134 participants (6.4%) who
completed our questionnaire were excluded from analysis because
they reported having sex with only women, reported never having
sex, or did not specify a history of sexual partners. 39 individuals
(1.9%) were also excluded because they did not report prior testing
for HIV or because they were tested for HIV but chose not to
report the HIV test result. In addition, 190 individuals (9.1%)
reported testing positive for HIV. Finally, 670 individuals (32.1%)
were excluded because they did not know or specify whether they
had ever been tested for or vaccinated against hepatitis B. Thus, of
2,085 men 18 years of age or older who were eligible to complete
our survey, 1,052 (50.5%) were included in our analyzed study
population [Figure 1].
Table S1 describes the demographic and behavioral character-
istics of the study population. Median age was 26. Based on
examination of estimated logit plots, we divided age into three
categories – 18–19, 20–31, and .31. More than 60% of the study
population was non-Hispanic white, one fifth was non-Hispanic
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participants were generally educated: approximately 80% reported
at least having received an Associate’s degree, attended technical
school or completed some college coursework. More than half of
all participants were insured by a private insurance company or a
health maintenance organization. Unprotected anal intercourse at
last sex with the most recent male sex partner (MRMSP) was
common among study participants (46.7%); however, few
participants reported drug use at last sex with their MRMSP
(5.8%). More than 80% of all participants reported visiting a
healthcare provider in the past year, but only one sixth of all
participants reported that their healthcare provider recommended
a hepatitis B vaccine during a recent visit.
Nearly three quarters of all participants reported ever being
tested for hepatitis B; 50 (4.8%) reported they had ever been told
by a healthcare provider that they were hepatitis B-positive. 679
(64.5%) reported ever being vaccinated against hepatitis B. Table
S2 describes the bivariate association of each independent variable
with vaccination status among the 1,002 hepatitis B-negative men
in our study population. The odds of vaccination were approxi-
mately 50% lower for men aged greater than 31, compared to men
aged 18–19 years. Higher educational attainment was associated
with higher odds of vaccination: when compared to men with a
high school education or less, the odds of vaccination were nearly
twice as great for men who reported graduating from college, and
were 60% higher for men who reported having received an
Associate’s degree, attended technical school or completed some
college coursework.
Providers may screen their patients for hepatitis B antibodies in
order to determine whether they are eligible to be vaccinated
against the virus; hepatitis B testing was strongly associated with
vaccination, as the odds of vaccination were 3.6 times higher
Figure 1. Derivation of study population from online cohort of MSM, United States, October–December 2010.
doi:10.1371/journal.pone.0030609.g001
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compared to men who had never been tested. Although drug use
at last sex was rare among all participants in our study, it remained
associated with hepatitis B vaccination: the odds of vaccination
were 50% lower among men who used drugs at last sex with their
MRMSP, when compared to men who did not use drugs at last
sex. Having been seen by a healthcare provider in the last year was
also associated with hepatitis B vaccination, especially when the
provider knew that the respondent had sex with men and when the
provider recommended that the individual be vaccinated against
hepatitis B. The odds of vaccination were 80% greater among men
whose providers knew they had sex with men, when compared to
men whose providers were unaware of their patient’s male-male
sexual behavior. The odds of vaccination were nearly five times
higher among men whose providers recommended that they
receive a vaccine for hepatitis B, when compared to individuals
whose providers did not recommend vaccination.
Table S2 also presents the independent variables that remained
associated with hepatitis B vaccination in the multivariable logistic
regression model. Age, having been tested for hepatitis B,
educational status, and having a provider recommendation for
vaccination were all associated with significantly higher or lower
odds of vaccination. (63 respondents who either reported being
infected with hepatitis B [n=50] or were missing information on
statistically significant covariates [n=13] were excluded from the
model.) The odds of vaccination among MSM increased as men
reported completing successively higher levels of education:
receiving an Associate’s degree, completing some college course-
work, or having attended technical school was associated with a
two-fold increase in the odds of vaccination, when compared to
men with a high school education or less. By contrast, completing
a college education was associated with a three-fold increase in the
odds of vaccination. The odds of vaccination were four times
greater among men whose healthcare providers recommended a
vaccine for hepatitis B at a visit in the last year, when compared to
men whose providers did not recommend vaccination. One
significant interaction was identified: age interacted significantly
with having been screened for antibodies to hepatitis B [Table S2].
Significant multicollinearity was not observed between any two
independent predictors or their interactions.
Table 1 describes the reasons why HIV-negative men who
reported they were not vaccinated against hepatitis B had never
been vaccinated. More than half of these men reported that they
had never been offered a vaccine by a healthcare provider, and
one in five did not know that vaccination was recommended.
Approximately one third of men were not aware that a hepatitis B
vaccine was available and one quarter did not perceive themselves
to be at increased risk of infection with hepatitis B. Overall, 90% of
unvaccinated men reported one of the above reasons as the main
reason why they had never been vaccinated against hepatitis B.
Main reasons for not being vaccinated were generally similar to
the reasons identified when men could endorse multiple reasons
for never having been vaccinated [Table 1].
Discussion
We found that nearly two thirds of HIV-negative participants
who participated in a web-based sexual health survey of MSM
between October and December 2010 reported ever being
vaccinated against hepatitis B. Educational status, age, having
been tested for hepatitis B, and provider-based recommendation of
vaccination were significantly associated with self-reported receipt
of vaccination. Based on these data, additional efforts are needed
to improve hepatitis B vaccination rates in MSM. Understanding
which factors are associated with self-reported vaccination will
help clinicians and health promotion specialists tailor their
immunization campaigns in a targeted effort to reach presently
underserved segments of the population.
Previous studies of hepatitis B vaccination in MSM in the
United States have estimated that the self-reported prevalence of
vaccination is between 3% and 70% [8,10,12–14,16–18,20].
Although the results from our web-based survey approach the
upper bound for the previously described, self-reported prevalence
of vaccination in this population, it should be noted that a majority
of other studies [8,12,13,17,18] found that no more than 40% of
MSM had been vaccinated against hepatitis B. Furthermore, the
Table 1. Reasons for lack of hepatitis B vaccination among 323 unvaccinated, HIV- and hepatitis B-negative men who have sex
with men, United States, October–December 2010.
Any Main
Reason not vaccinated n( % )
a n( % )
b,
c
A vaccine was never offered to you 174 (53.9) 92 (41.8)
You didn’t know there was a vaccine that prevents infection with hepatitis B 91 (28.2) 49 (22.3)
You believe yourself to be at low risk of contracting hepatitis B 80 (24.8) 43 (19.6)
You did not know you were eligible to receive a vaccine for hepatitis 68 (21.1) 13 (5.9)
A vaccine was offered to you, but you refused to receive it 12 (3.7) 8 (3.6)
There was no one assigned to you (i.e. doctor, nurse practitioner, etc) who could provide you with health care services,
including immunizations
17 (5.3) 5 (2.3)
The vaccine for hepatitis B costs too much 13 (4.0) 5 (2.3)
You were unable to travel to a location that provides vaccinations because of circumstances that were out of your control
(disability, live in rural area, etc)
4 (1.2) 2 (0.9)
You were incarcerated 2 (0.6) 2 (0.9)
You believed that you may already have symptoms of hepatitis B and therefore a vaccine would not work 3 (0.9) 1 (0.5)
aPercents may sum to more than 100 because respondents could specify more than 1 reason why they were not vaccinated against hepatitis B.
bPercents sum to more than 100 due to rounding.
c103 respondents not vaccinated against hepatitis B either did not specify a reason for not being vaccinated, did not know why they were not vaccinated or, if they
specified more than 1 reason for not being vaccinated, did not specify a main reason.
doi:10.1371/journal.pone.0030609.t001
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2009 – 70% – may not be representative of all MSM in the United
States because the authors solicited participation from individuals
who were presumed to be more likely to be cognizant of their
overall health and to seek to remain healthy.
Nevertheless, it is not implausible that we measured such a high
prevalence of hepatitis B vaccination in our study population,
given the demographics of our respondents. A hepatitis B vaccine
was licensed in the United States in 1981 and universal infant
vaccination recommendations have been in force since 1991 [4].
Therefore, men who are younger than 32 years of age, and
especially those between the ages of 18 and 20, are more likely to
have been vaccinated against hepatitis B. Men who are now
between the ages of 18 and 20 would have likely been required to
receive a hepatitis B vaccine in order to enter kindergarten, while
men in their mid-twenties may have received a hepatitis B series as
an early adolescent. Furthermore, men who pursued education
beyond a high school or general equivalency diploma would have
been likely to have received a vaccine for hepatitis B as a
requirement for matriculation into a college or university.
Unfortunately, however, one cannot assume that all men under
the age of 32 received a hepatitis B vaccine as an infant, young
child or adolescent. Like any other young person, a young MSM
may not receive a vaccine for hepatitis B as a child because his
parents may not be aware of vaccine recommendations or may
object to vaccination because they have concerns over the safety of
the vaccine.
Many prior studies have reported prevalences of vaccination in
populations of MSM that were much older than the population
surveyed in our study [8,13,14,16,20]. Thus, differences in
vaccination prevalence between our study and prior reports may
represent a cohort effect, because the predominantly older men in
earlier studies were not children when the universal childhood
vaccination recommendations were originally released in 1991 and
subsequently revised in 1997. Compared to younger men, older
men may more often only be vaccinated against hepatitis B
because they are concerned that they may have been exposed to
the virus and are seeking post-exposure prophylaxis.
Each of the factors significantly associated with hepatitis B
vaccination among MSM in our study – age [8,11,12,14,20],
educational status [11,12], hepatitis B testing status [17] and
history of provider recommendation of vaccination [8] – have also
been found to be associated with vaccination in prior studies of
MSM in the United States. In our study, we found that the odds of
vaccination decreased with increasing age; however, men in their
twenties and early thirties were more likely to be vaccinated if they
had never been tested for hepatitis B, whereas older men were
more likely to be vaccinated if they had ever been tested. A
negative association between age and hepatitis B vaccination has
been reported in many prior studies [8,11,12,14,20]. However,
these studies have generally been conducted only in urban areas
and have not included respondents from throughout the United
States. Nationally representative surveys have enrolled only
younger MSM (under the age of 30) [9–12]. However, most
studies that were conducted more than ten years ago in select US
cities, as well as over the Internet, examined self-reported hepatitis
B vaccination prevalence in older MSM: most of their respondent
profiles indicated a mean or median age of 30 years of age or older
[13,16,20]. More recently, studies of vaccine prevalence among
MSM have also been more likely to have older MSM respondents
[8,14]. We also found that men with higher levels of education
were more likely to be vaccinated against hepatitis B. MacKellar et
al reported a significant association between education and higher
odds of vaccination in a model that also included age, city of
residence, HIV testing status and diagnoses, the degree to which a
man had ever told others that he was homosexual or bisexual, and
whether he had a relationship with a healthcare provider.
However, with respect to education, MacKellar et al modeled
vaccination status as a function of a young man’s current
educational status [11]. As a result, it was not possible to assess
the degree to which a man’s level of education may simultaneously
influence both his perception of infection risk associated with his
sexual behavior and his likelihood of accepting vaccination. Also,
the results of MacKellar et al were not directly comparable with
ours. Weinbaum et al also reported a significant association
between education and higher odds of vaccination in a model that
included age, race, city of residence and whether a man had a
regular source of healthcare [12]; however, they did not provide
quantitative estimates of the association between education and
receipt of vaccination.
We found that the odds of vaccination were more than four
times higher among men whose healthcare providers recom-
mended vaccination, when compared to men whose providers did
not recommend vaccination. A 2009 study by Gilbert et al found
that the odds of vaccination were nearly 18 times higher among
men whose providers recommended hepatitis B vaccination, when
compared to men whose providers did not recommend vaccina-
tion [8]; however, the bivariate association that they reported did
not simultaneously control for the effects of confounding factors, as
did our analysis.
Our study furthers knowledge of hepatitis B vaccination
prevalence among HIV-negative MSM and factors significantly
associated with vaccination because we evaluated self-reported
vaccination among a group of MSM recruited from across the
United States and from both urban and rural areas. Furthermore,
the authors are aware of few studies of hepatitis B vaccination
prevalence that examine this trend exclusively in HIV-negative
individuals [15,21]. In addition, we not only evaluated the
relationship of covariates significantly associated with vaccination
in a bivariate analysis, but we also developed a multivariable
model to control for the effects of all statistically significant
covariates simultaneously.
Among unvaccinated men in our study, we found that nearly
nine in ten reported that their provider did not offer vaccination,
they were unaware that a vaccine exists, or they did not perceive
themselves to be at risk for hepatitis B infection, as the main reason
they were never vaccinated against hepatitis B. Although previous
studies have not reported the primary reason for lack of
vaccination in their analyses and have instead described the range
of reasons MSM report why they have never been vaccinated
against the virus [8,10–13,17], the continued opportunity for
providers to more actively promote disease prevention and
vaccination in their consultations is clear. More than 40% of
unvaccinated respondents in our study reported that the main
reason that they were not vaccinated against hepatitis B was
because a vaccine was never offered to them. Encouragingly,
provider-recommended vaccination is effective at encouraging
MSM to be vaccinated against the virus, as evidenced by a four-
fold increase in the odds of vaccination among men in our study
whose providers recommended vaccination, when compared with
men whose providers did not.
Providers may not recommend vaccination to all eligible MSM
because they are not aware that some patients engage in male-
male sexual behavior. However, if a hepatitis B-susceptible MSM
shares his male-male sexual behavior with his healthcare provider,
the provider may be more likely to recommend vaccination [11].
Gilbert et al found that the odds of vaccination was more than two
times higher among individuals who told their healthcare provider
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not [8]. In addition, a 2009 web-based study of provider-
recommended HIV testing among MSM who saw a healthcare
provider in the past 12 months found that men who shared their
male-male sexual behavior with their providers were at least eight
times more likely to be offered HIV testing, when compared to
men who did not share their history of same-sex partners with
their providers [22].
General delivery of health services to MSM, and especially
prevention of HIV and acute hepatitis B infection, may therefore
be improved if a healthcare provider knows that her patient
engages in male-male sexual behavior. However, many MSM
remain hesitant to disclose the fact that they have sex with other
men to their providers [8,11,22]. Therefore, healthcare providers
are encouraged to ask patients about whom they have sex with in a
non-judgmental way, to include asking about male, female, or lack
of any sexual partners. Providers should then screen all men who
report male partners for serological evidence of past hepatitis B
infection or vaccination, and offer vaccination to those men who
are eligible to receive it. Providers and health promotion specialists
should especially focus their efforts toward screening and
vaccinating older, as well as socioeconomically disadvantaged,
individuals.
There are several limitations inherent in our web-based sexual
health survey of MSM in the United States. Because individuals
were recruited over the Internet rather than in person by a trained
interviewer, individuals who did not have access to the Internet
during the study period were unable to participate and are not
represented in the study population. In addition, a majority of our
study participants were white. However, few prevalence studies of
hepatitis B vaccination in MSM have chosen minority individuals
as their population of interest [23,24]. As more than half of our
study population was under the age of 30, our results have limited
generalizability to older individuals. Because our study was a cross-
sectional survey of individual hepatitis B testing and vaccination
status, demographic characteristics, sexual and non-sexual risk
behaviors, and recent provider-participant interaction among
HIV-negative MSM, we cannot determine whether factors
significantly associated with vaccination preceded vaccination or
whether other criteria for causality might have been met.
Because information on the outcome of interest and potentially
associated covariates was ascertained by self-report, misclassifica-
tion bias is likely to have occurred. Furthermore, although we
restricted our study population to MSM who were HIV-negative
or whose HIV status was unknown, there may have been some
misclassification of self-reported HIV status. In addition, individ-
uals may not remember whether they received the hepatitis B
vaccine or because they are not aware that such a vaccine exists,
they may mistake other shots or vaccines for the hepatitis B
vaccine. We excluded participants who did not know or who chose
not to specify whether they had ever received a hepatitis B vaccine.
If these participants had otherwise been included in our study, we
would have been required to assume that they were unvaccinated;
as a result, the proportion of vaccinated individuals would have
been incorrectly underestimated. However, it is not possible to
estimate whether potential recall bias among individuals included
in our study population – who reported knowing whether or not
they were vaccinated against hepatitis B – led to an underestima-
tion or overestimation of the prevalence of vaccination in this
population.
In our study, we measured the prevalence of sexual and non-
sexual risk behaviors that occurred at last sex with a study
participant’s MRMSP; however, as an example, a man’s use of
drugs at last sex with his MRMSP is not necessarily indicative of
his typical drug use behavior during sex. Engaging in these high-
risk sexual and non-sexual risk behaviors over long periods of time
may be more significantly associated with vaccination than was
engaging in these behaviors at last sex. Future studies could
address this limitation by developing sexual and non-sexual risk
behavior questions that incorporate an ordinal scale and evaluate
whether MSM have engaged in such behaviors for more
prolonged periods of time.
In addition, many of the reportable sexual and non-sexual risk
behaviors, such as unprotected anal intercourse and drug use, are
not often perceived to be socially desirable, and individuals may be
less likely to report engaging in these activities. The prevalences of
these behaviors in the population are likely to be underestimated.
However, we do not have any reason to believe that men who had
beenvaccinated against hepatitis B wereany more or lesslikely than
men who had never been vaccinated to underreport socially
undesirable behaviors. Therefore, it remains unlikely that either
unprotected anal intercourse or drug use during last sex (or both)
withthe MRMSP actually havea significant associationwithreceipt
of hepatitis B vaccination that was obscured by this underreporting.
In addition to the limitations above, we recognize that internet-
based surveys likely result in biased samples of men with respect to
socioeconomic status, and often under-represent racial/minority
MSM. Less gay-identified men would likely not have been reached
by our advertising, which targeted Facebook participants based on
their self-identified interest in men. Furthermore, because we did
not have face to face contact with our participants, we cannot rule
out the possibility that some of our respondents were not as they
represented themselves. For example, women or heterosexual men
could have responded to our survey, presenting themselves as
MSM. However, we recruited respondents by targeting them for
advertising based on their Facebook profile. Participants could not
access the survey by simply entering a public URL. Therefore, we
think it unlikely that women or heterosexual men created
Facebook profiles identifying themselves as gay men, simply to
gain access to an unincentivized survey. Ideally, one might seek to
validate self-reported information on previous hepatitis testing or
vaccination in medical records to reduce the possibility of
misclassification of our outcomes.
Nearly one-third of HIV-negative MSM who participated in a
web-based survey of their sexual and non-sexual life experiences
reported never having been vaccinated against hepatitis B.
Approximately 90% of these men reported not being vaccinated
because they did not believe themselves to be at high risk of being
infected with hepatitis B, or because they did not know about the
availability of a vaccine for or were never offered vaccination
against hepatitis B. Because men whose providers recommended
vaccination against hepatitis B were four times more likely to be
vaccinated against the virus than men whose providers did not
recommend vaccination, providers should view consultations with
their male patients who have sex with men as meaningful
opportunities to offer vaccination to vulnerable patients. In
addition, according to our data, providers and health promotion
specialists should target their vaccination campaigns toward older
MSM and those MSM of lower socioeconomic status.
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